Skip to content

Delivering on genetic medicines

Aera’s protein nanoparticle (PNP) delivery platform leverages the discovery of endogenous, human proteins that can self-assemble to form capsid-like structures and that can package and transfer nucleic acid cargo. This platform has the potential to address many of the limitations of today’s delivery technologies and to enable various genetic medicine modalities.

Our Science

Building a leading genetic medicines company


Aera is led by a distinguished team of scientists and company builders.

Are you passionate about science and making an impact? Join us.

View Careers